Install
News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals
- 39articles · 30d
- 15+ hour agolatest article
- Aug 17, 2026earliest in window
- 92%with images
- 132avg words
- Medical 34
- Health & Wellness 29
- Health 27
- Business & Industrial 10
- Economy, Business & Finance 5
- Finance & Business 4
- Science & Technology 4
- Human Interest 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Scandal-hit KPMG still holds $37 million in health department work
1+ day, 3+ hour ago (104+ words) PharmaDispatch Scandal-hit KPMG still holds $37 million in health department work According to the document released in response to a Freedom of Information request, the firm held 24 active contracts with the department, worth a combined $37.3 million as at 22 May 2026. … Todd Stephenson…...
Canberra details tax changes with limited concessions for some innovators
1+ day, 5+ hour ago (100+ words) PharmaDispatch Canberra details tax changes with limited concessions for some innovators AusBiotech has welcomed concessions to changes to the R&D Tax Incentive and Capital Gains Tax but remains concerned about the potential impact on emerging life sciences companies. … Rare…...
Australian biotech Immuron takes gut health treatment to the US market - BioPharmaDispatch
1+ week, 18+ hour ago (121+ words) Australian biotech Immuron takes gut health treatment to the US market PharmaDispatch Australian biotech Immuron takes gut health treatment to the US market Melbourne-based Immuron is preparing to bring its digestive health product PROIBS to American shelves after striking an…...
Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage - BioPharmaDispatch
1+ week, 18+ hour ago (124+ words) Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage PharmaDispatch Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage Neurizon Therapeutics, the Melbourne-based biotechnology company developing…...
CSL agrees to price certainty and a bigger US manufacturing footprint
1+ week, 6+ day ago (144+ words) pharmadispatch.com CSL agrees to price certainty and a bigger US manufacturing footprint CSL is one of the nine latest companies to reach pricing agreements with the US Trump administration, which also includes a major expansion by the Australian company…...
Alterity secures option underwriting as it prepares for pivotal MSA trial
2+ week, 17+ hour ago (140+ words) PharmaDispatch Alterity secures option underwriting as it prepares for pivotal MSA trial Alterity Therapeutics has secured an underwriting agreement that could provide at least $4.2 million in additional funding as the company prepares to begin its planned Phase 3 clinical trial of…...
Sandoz earns workplace recognition amid push for medicine access
2+ week, 3+ day ago (132+ words) PharmaDispatch Sandoz earns workplace recognition amid push for medicine access Sandoz Australia and New Zealand has been named among Australia’s Top 100 Best Workplaces for 2026, ranking 15th in the medium-sized business category and standing as the only pharmaceutical company included in that…...
Professor Brandon Wainwright appointed to lead QIMR Berghofer
2+ week, 5+ day ago (118+ words) PharmaDispatch Professor Brandon Wainwright appointed to lead QIMR Berghofer QIMR Berghofer, one of Australia's leading medical research institutions, has appointed internationally recognised geneticist Professor Brandon Wainwright AM as its next Director and Chief Executive Officer. … Australian study finds maternal RSV…...
Acrux brings experienced clinical leader aboard to advance female testosterone program
3+ week, 17+ hour ago (114+ words) PharmaDispatch Acrux brings experienced clinical leader aboard to advance female testosterone program Acrux has appointed physician and biopharmaceutical executive Dr Jolanta Airey as its chief medical officer, strengthening its leadership team as it prepares to advance its female testosterone treatment…...
Avecho moves to deepen global partnering push as CBD insomnia program advances
3+ week, 17+ hour ago (102+ words) PharmaDispatch Avecho moves to deepen global partnering push as CBD insomnia program advances Avecho chief executive Dr Paul Gavin said the timing reflected the program's growing commercial relevance as it approaches a critical clinical and regulatory stage. … July recommendations across…...